Market Research Industry Reports

Partnerships, Licensing, Investments and M&A Deals and Trends for 2017 in Pharmaceuticals

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Partnerships, Licensing, Investments and M&A Deals and Trends for 2017 in Pharmaceuticals

Summary

GlobalDatas "Partnerships, Licensing, Investments and M&A Deals and Trends for 2017 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in 2017. The report portrays detailed comparative data on the number of deals and their value in the last five years, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

The pharmaceutical and healthcare industry recorded a marginal increase in the number of number deals and a decrease in deal values in 2017 with 4,840 deals worth USD362 billion, as compared to 4,838 deals worth USD404.9 billion in 2016. The oncology market recoded 1,654 deals in 2017, as compared to 1,596 deals in 2016. North America recorded a decrease in the number of deals and deal values with 3,040 deals worth USD225.8 billion in 2017, as compared to 3,148 deals worth USD271.6 billion in 2016. Licensing agreements recorded a marginal increase in the receipt of upfront payments with USD4.4 billion in 2017, as compared to USD4.3 billion in 2016.

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and womens health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the five years.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceutical & Healthcare, Global, Deals Summary 13
2.1 Pharmaceutical & Healthcare, Global, Deals Analysis, 2017 13
2.1.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, 2017 by Quarter 15
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, 2017 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, 2017 18
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, 2017 19
2.5 Pharmaceuticals & Healthcare, Top Deals, Global, Summaries, 2017 20
2.5.1 Johnson & Johnson Acquires Actelion for USD30 Billion 20
2.5.2 Gilead Sciences Acquires Kite Pharma for USD11.9 Billion 20
2.5.3 AstraZeneca Enters into Agreement with Merck 21
2.5.4 INC Research and inVentiv Health Merge 21
2.5.5 Becton, Dickinson Raises USD10.5 Billion in Public Offering of Notes 22
2.5.6 Thermo Fisher Scientific Acquires 99% Stake in Patheon for USD7.2 Billion 22
2.5.7 Baotou Dongbao Bio Tech to Raise up to USD5.6 Billion in Private Placement of Shares 23
2.5.8 Anthem Raises USD5.5 Billion in Private Placement of Notes 23
2.5.9 Takeda Pharma Acquires Ariad Pharma for up to USD5.2 Billion in Tender Offer 23
2.5.10 Pamplona Capital Management Acquires Parexel International for USD5 Billion 23
3 Pharmaceuticals & Healthcare, Global, Deal Summary, by Type 25
3.1 Pharmaceuticals & Healthcare, Global, M&A, 2017 25
3.1.1 Pharmaceuticals & Healthcare, Global, M&A, 2017 by Quarter 26
3.1.2 Top M&A Deals in 2017 27
3.1.3 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, 2017 28
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2017 29
3.2.1 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2017 by Quarter 30
3.2.2 Pharmaceuticals & Healthcare, Global, IPO Deals, 2017 31
3.2.3 Top IPOs in 2017 32
3.2.4 Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, 2017 32
3.2.5 Top Secondary Offerings in 2017 33
3.2.6 Pharmaceuticals & Healthcare, Global, PIPE Deals, 2017 34
3.2.7 Top PIPE Deals in 2017 35
3.2.8 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, 2017 35
3.3 Pharmaceuticals & Healthcare, Global, Debt Offering Deals, 2017 37
3.3.1 Pharmaceuticals & Healthcare, Global Debt Offerings, 2017 by Quarter 38
3.3.2 Pharmaceuticals & Healthcare, Global, Public Debt Offerings, 2017 39
3.3.3 Top Public Debt Offerings in 2017 40
3.3.4 Pharmaceuticals & Healthcare, Global, Private Debt Placements, 2017 40
3.3.5 Top Private Debt Placements in 2017 41
3.3.6 Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, 2017 42
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, 2017 43
3.4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, 2017 by Quarter 44
3.4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, 2017 45
3.4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Value (US$ m), 2017 47
3.4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2017 48
3.4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, 2017 49
3.4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), 2017 50
3.4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2017 51
3.4.8 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, 2017 53
3.4.9 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, 2017 53
3.4.10 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, 2017 54
3.5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2017 55
3.5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2017 by Quarter 56
3.5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, 2017 57
3.5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Value (US$ m), 2017 58
3.5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2017 59
3.5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2017 60
3.5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2017 61
3.5.7 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Values, 2017 63
3.5.8 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Upfront Payment, 2017 64
3.5.9 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Milestone Payment, 2017 64
3.6 Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2017 65
3.6.1 Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2017 by Quarter 66
3.6.2 Top Private Equity Deals in 2017 67
3.6.3 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, 2017 68
3.7 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, 2017 69
3.7.1 Pharmaceuticals & Healthcare, Global, Venture Financing Deals, 2017 by Quarter 70
3.7.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2017 71
3.7.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2017 72
3.7.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, 2017 73
3.7.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 74
3.7.6 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, 2017 75
3.7.7 Top Venture Financing Deals in 2017 76
4 Pharmaceuticals & Healthcare, Global, Deal Summary, By Market 77
4.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2017 77
4.1.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2017 by Quarter 78
4.1.2 Oncology - Deals of the Year 79
4.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2017 82
4.2.1 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2017 by Quarter 83
4.2.2 Central Nervous System - Deals of the Year 84
4.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2017 87
4.3.1 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2017 by Quarter 88
4.3.2 Infectious Disease - Deals of the Year 89
4.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, 2017 92
4.4.1 Pharmaceuticals & Healthcare, Global, Immunology Deals, 2017 by Quarter 93
4.4.2 Immunology - Deals of the Year 94
4.5 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2017 97
4.5.1 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2017 by Quarter 98
4.5.2 Cardiovascular - Deals of the Year 99
4.6 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2017 102
4.6.1 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2017 by Quarter 103
4.6.2 Metabolic Disorders - Deals of the Year 104
4.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2017 108
4.7.1 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2017 by Quarter 109
4.7.2 Gastrointestinal - Deals of the Year 110
5 Pharmaceuticals & Healthcare, Deal Summary, By Geography 113
5.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2017 113
5.1.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2017 by Quarter 114
5.1.2 North America - Deals of the Year 115
5.2 Pharmaceuticals & Healthcare, European Region Deals, 2017 118
5.2.1 Pharmaceuticals & Healthcare, Europe, Deals, 2017 by Quarter 120
5.2.2 Europe - Deals of the Year 121
5.3 Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, 2017 124
5.3.1 Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, 2017 by Quarter 125
5.3.2 Asia-Pacific - Deals of the Year 126
5.4 Pharmaceuticals & Healthcare, Rest of the World (ROW) Deals, 2017 128
5.4.1 Pharmaceuticals & Healthcare, Rest of the World Deals, 2017 by Quarter 129
5.4.2 Rest of the World - Deals of the Year 130
6 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 133
6.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, 2017 133
6.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, 2017 135
7 Further Information 136
7.1 Methodology 136
7.2 About GlobalData 137
7.3 Contact Us 137
7.4 Disclosure information 137
7.5 Disclaimer 138

List Of Tables

1.1 List of Tables
Table 1: Pharmaceutical & Healthcare, Global, Deals Summary, Number of Deals and Deal Value (US$ m), 2013 - 2017 14
Table 2: Pharmaceuticals & Healthcare, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2017-Q4 2017 16
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), 2017 18
Table 4: Pharmaceuticals & Healthcare, Top Deals, Global, 2017 19
Table 5: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 26
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 27
Table 7: Pharmaceuticals & Healthcare, Global, Top M&A Deals, 2017 27
Table 8: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, 2017 28
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 29
Table 10: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 30
Table 11: Pharmaceuticals & Healthcare, Global, IPO Deals, Deals Summary, Number of Deals and Deal Value (US$ m), 2013 - 2017 31
Table 12 Pharmaceuticals & Healthcare, Global, Top IPOs, 2017 32
Table 13: Pharmaceuticals & Healthcare, Global, Secondary Offerings, Deals Summary, Number of Deals and Deal Value (US$ m), 2013 - 2017 33
Table 14: Pharmaceuticals & Healthcare, Global, Top Secondary Offerings, 2017 33
Table 15: Pharmaceuticals & Healthcare, Global, PIPEs, Deals Summary, Number of Deals and Deal Value (US$ m), 2013 - 2017 34
Table 16: Pharmaceuticals & Healthcare, Global, Top PIPE Deals, 2017 35
Table 17: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), 2017 36
Table 18: Pharmaceuticals & Healthcare, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 37
Table 19: Pharmaceuticals & Healthcare, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 38
Table 20: Pharmaceuticals & Healthcare, Global, Public Debt Offerings, Deals Summary, Number of Deals and Deal Value (US$ m), 2013 - 2017 39
Table 21: Pharmaceuticals & Healthcare, Global, Top Public Debt Offerings, 2017 40
Table 22: Pharmaceuticals & Healthcare, Global, Private Debt Placements, Deals Summary, Number of Deals and Deal Value (US$ m), 2013 - 2017 41
Table 23: Pharmaceuticals & Healthcare, Global, Top Private Debt Placements, 2017 41
Table 24: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Summary, Number of Deals and Deal Values (US$ m), 2017 42
Table 25: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), 2013 - 2017 43
Table 26: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 44
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2017 46
Table 28: Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payment and Deal Values (US$ m), 2017 47
Table 29: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2017 48
Table 30: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2017 50
Table 31: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), 2017 52
Table 32: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payment and Deal Values (US$ m), 2017 53
Table 33: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, 2017 53
Table 34: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, 2017 54
Table 35: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 55
Table 36: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 56
Table 37: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$ m), 2017 57
Table 38: Pharmaceuticals & Healthcare, Licensing Agreements, Upfront & Milestone Payments and Deal Values (US$ m), 2017 58
Table 39: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront & Milestone Payments and Deal Values (US$ m), 2017 59
Table 40: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q4 2015 - Q4 2017 61
Table 41: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Values (US$ m), 2017 63
Table 42: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payment and Deal Values (US$ m), 2017 63
Table 43: Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Upfront Payment, 2017 64
Table 44: Pharmaceutical & Healthcare, Global, Top Licensing Agreements, by Milestone Payment, 2017 64
Table 45: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 65
Table 46: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 66
Table 47: Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, 2017 67
Table 48: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$ m), 2017 68
Table 49: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 69
Table 50: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 70
Table 51: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), 2017 72
Table 52: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$ m), 2017 73
Table 53: Pharmaceutical & Healthcare, Global, Top VC Backed Companies, 2017 74
Table 54: Pharmaceuticals & Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$ m), 2017 75
Table 55: Pharmaceuticals & Healthcare, Top Venture Financing Deals, Global, 2017 76
Table 56: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 78
Table 57: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 79
Table 58: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 83
Table 59: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 84
Table 60: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 88
Table 61: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 89
Table 62: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 93
Table 63: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 94
Table 64: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 98
Table 65: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 99
Table 66: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 103
Table 67: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 104
Table 68: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 109
Table 69: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 110
Table 70: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Value (US$ m), 2013 - 2017 114
Table 71: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Value (US$ m), Q1 2017-Q4 2017 115
Table 72: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Value (US$ m), 2013 - 2017 120
Table 73: Pharmaceuticals & Healthcare, European Region Deals, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2017-Q4 2017 121
Table 74: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Value (US$ m), 2013 - 2017 125
Table 75: Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2017-Q4 2017 126
Table 76: Pharmaceuticals & Healthcare, Rest of the World Deals, Deals Summary, Number of Deals and Deal Value (US$ m), 2013 - 2017 129
Table 77: Pharmaceuticals & Healthcare, Rest of the World Deals, Deals Summary, Number of Deals and Deal Value (US$ m), Q1 2017-Q4 2017 130
Table 78: Pharmaceuticals & Healthcare, Global,, Top Financial Advisors, M&A, Number of Deals and Deal Value (US$ m), 2017 134
Table 79: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$ m), 2017 135

List Of Figures

1.2 List of Figures
Figure 1: Pharmaceutical & Healthcare, Global, Number of Deals and Deal Value (US$ m), 2013- 2017 13
Figure 2: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Value (US$ m), Q1 2017-Q4 2017 15
Figure 3: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), 2017 17
Figure 4: Pharmaceuticals & Healthcare, Global, Deal Values (%), 2017 18
Figure 5 Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), 2013 - 2017 25
Figure 6 Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 26
Figure 7: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2017 28
Figure 8: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), 2013 - 2017 29
Figure 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 30
Figure 10: Pharmaceuticals & Healthcare, Global, IPO Deals, Number of Deals and Deal Value (US$ m), 2013 - 2017 31
Figure 11: Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, Number of Deals and Deal Value (US$ m), 2013 - 2017 32
Figure 12: Pharmaceuticals & Healthcare, Global, PIPE Deals, Number of Deals and Deal Value (US$ m), 2013 - 2017 34
Figure 13: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2017 35
Figure 14: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$ m), 2013 - 2017 37
Figure 15: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 38
Figure 16: Pharmaceuticals & Healthcare, Global, Public Debt Offering Deals, Number of Deals and Deal Value (US$ m), 2013 - 2017 39
Figure 17: Pharmaceuticals & Healthcare, Global, Private Debt Placements, Number of Deals and Deal Value (US$ m), 2013 - 2017 40
Figure 18: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2017 42
Figure 19: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), 2013 - 2017 43
Figure 20: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 44
Figure 21: Pharmaceuticals & Healthcare, Global, Partnership Deals Break down (%), 2017 45
Figure 22: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2017 45
Figure 23: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), 2017 47
Figure 24: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2017 48
Figure 25: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2017 49
Figure 26: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2017 50
Figure 27: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2017 51
Figure 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), 2013 - 2017 55
Figure 29: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 56
Figure 30: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$ m), 2017 57
Figure 31: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Upfront & Milestone Payments and Deal Values (US$ m), 2017 58
Figure 32: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2017 59
Figure 33: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Number Of Deals, 2017 60
Figure 34: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Deal Values (US$ m), 2017 61
Figure 35: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payment and Deal Values (US$ m), 2017 62
Figure 36: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), 2013 - 2017 65
Figure 37: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 66
Figure 38: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2017 68
Figure 39: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), 2013 - 2017 69
Figure 40: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 70
Figure 41: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%), 2017 71
Figure 42: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Deal Values (%), 2017 72
Figure 43: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2017 73
Figure 44: Pharmaceuticals & Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$ m), 2017 75
Figure 45: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), 2013 - 2017 77
Figure 46: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 78
Figure 47: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), 2017, 2013 - 2017 82
Figure 48: Pharmaceuticals & Healthcare, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 83
Figure 49: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$ m), 2013 - 2017 87
Figure 50: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$ m), Q1 2017-Q4 2017 88
Figure 51: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), 2013 - 2017 92
Figure 52: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 93
Figure 53: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), 2013 - 2017 97
Figure 54: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 98
Figure 55: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), 2013 - 2017 102
Figure 56: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 103
Figure 57: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), 2013 - 2017 108
Figure 58: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017-Q4 2017 109
Figure 59: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Value (US$ m), 2013 - 2017 113
Figure 60: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Value (US$ m), Q1 2017-Q4 2017 114
Figure 61: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Value (US$ m), 2013 - 2017 118
Figure 62: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Value (US$ m), Q1 2017-Q4 2017 120
Figure 63: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Value (US$ m), 2013 - 2017 124
Figure 64: Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, Number of Deals and Deal Value (US$ m), Q1 2017-Q4 2017 125
Figure 65: Pharmaceuticals & Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$ m), 2013 - 2017 128
Figure 66: Pharmaceuticals & Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$ m), Q1 2017-Q4 2017 129
Figure 67: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Value (US$ m), 2017 133
Figure 68: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$ m), 2017 135

Partnerships, Licensing, Investments and M&A Deals and Trends for 2017 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for 2017 in PharmaceuticalsGlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends for 2017 in Pharmaceuticals , report is an essential source of

USD 3500View Report

Partnerships, Licensing, Investments and M&A Deals and Trends for February 2018 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for February 2018 in PharmaceuticalsGlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends for February 2018 in Pharmaceuticals , report is an essential

USD 1000View Report

Partnerships, Licensing, Investments and M&A Deals and Trends for February 2018 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for February 2018 in PharmaceuticalsGlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends for February 2018 in Pharmaceuticals , report is an essential

USD 1000View Report

Partnerships, Licensing, Investments and M&A Deals and Trends for January 2018 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for January 2018 in PharmaceuticalsGlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends for January 2018 in Pharmaceuticals , report is an essential

USD 1000View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 3500
  • Site Licence    USD 7000
  • Enterprise Wide Licence    USD 10500
$ 3500

Reports Details

Published Date : Apr 2018
No. of Pages :138
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube